Skip to main content

Aftera: Package Insert / Prescribing Info

Package insert / product label
Generic name: levonorgestrel
Dosage form: tablet
Drug class: Contraceptives

Medically reviewed by Drugs.com. Last updated on Jun 26, 2024.

Drug Facts

Active ingredient

Levonorgestrel 1.5 mg

Purpose

Emergency contraceptive

Indications and Usage for Aftera

for women to reduce chance of pregnancy after unprotected sex (if a contraceptive failed or if you did not use birth control)

Warnings

Allergy alert

Do not use if you have ever had an allergic reaction to levonorgestrel

Sexually transmitted diseases (STDs) alert

This product does not protect against HIV/AIDS or other STDs

Do not use

  • if you are already pregnant (because it will not work)
  • for regular birth control

Ask a doctor or pharmacist before use if you are taking efavirenz (HIV medication) or rifampin (tuberculosis treatment) or medication for seizures (epilepsy). These medications may reduce the effectiveness of levonorgestrel.

When using this product you may have

  • menstrual changes
  • tiredness
  • breast pain
  • nausea
  • headache
  • vomiting
  • lower stomach (abdominal) pain
  • dizziness

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control center right away.

Aftera Dosage and Administration

  • take as soon as possible within 72 hours (3 days) after unprotected sex. The sooner you take it the better it will work.
  • if you vomit within 2 hours after taking the medication, call a healthcare professional to find out if you should repeat the dose

Storage and Handling

  • read the instructions, warnings and enclosed product leaflet before use
  • do not use if carton is open or tear strip is removed or blister seal is broken or missing
  • store at 20-25°C (68-77°F)

Inactive ingredients

colloidal silicon dioxide, corn starch, lactose monohydrate, magnesium stearate, potato starch, talc

Questions?

Call 1-888-919-0780

Manufactured by:
Gedeon Richter, Ltd., Budapest, Hungary

PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box

This item is
electronically
protected

NDC 69536-103-88

Emergency Contraceptive
COMPARE TO PLAN B ONE-STEP®

Aftera®
LEVONORGESTREL 1.5 mg

Reduces chance of pregnancy
after unprotected sex.

One Tablet.
One Dose.

NOT FOR REGULAR BIRTH CONTROL

1 Tablet
Levonorgestrel
1.5 mg

PRINCIPAL DISPLAY PANEL - 1.5 mg Tablet Blister Pack Box
AFTERA
levonorgestrel tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69536-103
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
LEVONORGESTREL (UNII: 5W7SIA7YZW) (LEVONORGESTREL - UNII:5W7SIA7YZW) LEVONORGESTREL1.5 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)
STARCH, POTATO (UNII: 8I089SAH3T)
MAGNESIUM STEARATE (UNII: 70097M6I30)
TALC (UNII: 7SEV7J4R1U)
STARCH, CORN (UNII: O8232NY3SJ)
LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)
Product Characteristics
ColorWHITEScoreno score
ShapeROUNDSize8mm
FlavorImprint CodeG00
Contains
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:69536-103-881 in 1 BOX, UNIT-DOSE05/10/2018
11 in 1 BLISTER PACK; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
NDA AUTHORIZED GENERICNDA02199805/10/2018
Labeler - Foundation Consumer Healthcare LLC (079675882)

Frequently asked questions

View more FAQ

Medical Disclaimer